UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by CIBC Private Wealth Group LLC

CIBC Private Wealth Group LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,438,738 shares of the healthcare conglomerate's stock after selling 43,985 shares during the period. UnitedHealth Group makes up approximately 1.4% of CIBC Private Wealth Group LLC's holdings, making the stock its 11th largest position. CIBC Private Wealth Group LLC owned approximately 0.16% of UnitedHealth Group worth $754,647,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter worth $32,000. Pillar Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $40,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group during the third quarter worth about $57,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.1 %

UnitedHealth Group stock traded down $0.36 during trading on Wednesday, reaching $522.76. The company had a trading volume of 1,256,418 shares, compared to its average volume of 4,261,224. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $478.17 billion, a price-to-earnings ratio of 33.73, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock's 50 day moving average price is $509.06 and its two-hundred day moving average price is $542.96.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company posted $5.83 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by insiders.

Analysts Set New Price Targets

UNH has been the subject of a number of research reports. KeyCorp reiterated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Finally, StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.